Literature DB >> 8923358

The validity of self-reported diagnosis of rheumatoid arthritis: results from a population survey followed by clinical examinations.

T K Kvien1, A Glennås, O G Knudsrød, L M Smedstad.   

Abstract

OBJECTIVE: Self-reported diagnoses of rheumatic conditions are frequently used in epidemiological and clinical research. Our objectives were to examine the validity of patient self-reported rheumatoid arthritis (RA); and to assess the predictive value of symptoms, health status measures, and demographic variables with respect to the actual diagnosis.
METHODS: A postal survey was performed in Oslo of 10,000 randomly selected individuals between 20 and 79 years of age. Respondents reported musculoskeletal pain, stiffness, rheumatic diagnoses, disability, and mental distress. The patients reporting RA (either according to patient or doctor) were selected for further examination.
RESULTS: Of 5886 respondents (3670 with musculoskeletal pain or stiffness) 158 patients (2.7%) reported having RA diagnosed by doctor (n = 107) and/or according to their own opinion (n = 142). RA was confirmed by clinical examination in 35 of these 158 individuals (22%, CI 16,29). Patients with perceived and actual RA differed regarding self-reported presence of swollen joints and disability score. Multivariate analyses failed to identify a set of useful predictors for the correct diagnosis.
CONCLUSION: Patient self-reported diagnosis of RA is unreliable for research or clinical purposes.

Entities:  

Mesh:

Year:  1996        PMID: 8923358

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  30 in total

1.  Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis.

Authors:  T Uhlig; T K Kvien; J L Jensen; T Axéll
Journal:  Ann Rheum Dis       Date:  1999-07       Impact factor: 19.103

2.  Family history of cancer and non-malignant diseases and risk of childhood acute lymphoblastic leukemia: a Children's Oncology Group Study.

Authors:  Heather Zierhut; Martha S Linet; Leslie L Robison; Richard K Severson; Logan Spector
Journal:  Cancer Epidemiol       Date:  2011-10-21       Impact factor: 2.984

3.  Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population.

Authors:  Anders J Svendsen; Niels V Holm; Kirsten Kyvik; Per Hyltoft Petersen; Peter Junker
Journal:  BMJ       Date:  2002-02-02

4.  Rheumatoid arthritis: a commonly misused diagnosis by the general population.

Authors:  I T Gram; T Riise; Y Honda
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

5.  The case of tumour necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis: a budget impact analysis.

Authors:  Jan Sørensen; Lis S Andersen
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 6.  Criteria for TNF-targeted therapy in rheumatoid arthritis: estimates of the number of patients potentially eligible.

Authors:  T K Kvien; T Uhlig; I S Kristiansen
Journal:  Drugs       Date:  2001       Impact factor: 9.546

7.  Lifetime exposure to self-reported occupational noise and prevalent rheumatoid arthritis in the National Health and Nutrition Examination Survey (2011-2012).

Authors:  Angel M Dzhambov; Donka D Dimitrova
Journal:  Int J Occup Environ Health       Date:  2018-03-20

8.  The accuracy of administrative health data for identifying patients with rheumatoid arthritis: a retrospective validation study using medical records in Western Australia.

Authors:  Khalid Almutairi; Charles Inderjeeth; David B Preen; Helen Keen; Katrina Rogers; Johannes Nossent
Journal:  Rheumatol Int       Date:  2021-02-23       Impact factor: 2.631

9.  Personal and family medical history correlates of rheumatoid arthritis.

Authors:  Anneclaire J de Roos; Glinda S Cooper; Michael C Alavanja; Dale P Sandler
Journal:  Ann Epidemiol       Date:  2008-03-17       Impact factor: 3.797

10.  Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study.

Authors:  H S J Picavet; N Hoeymans
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.